مجلة كلية الطب · Published 2025-07-01 · DOI 10.32007/jfacmedbaghdad3122
Background: Coronary artery disease is a leading cause of death worldwide. Troponin is released into blood from patients with reversible myocardial ischemia. Stromelysin-2 is also involved in the development and progression of atherosclerosis by tissue remodeling and degradation of extracellular matrix proteins. Objectives: To investigate the role of serum high-sensitive cardiac troponin I (hs-cTn I) and Stromelysin-2 (Str-2) in the diagnosis and determination of the severity of coronary artery obstruction. Methods: This cross-sectional study was conducted on 125 subjects undergoing coronary angiography for suspicion of coronary artery disease in Baghdad Teaching Hospital/ Medical City complex/ Baghdad/ Iraq by the Department of Biochemistry/ College of Medicine/ University of Baghdad between March and December 2024. The participants were divided into three groups: Group I included 48 subjects with no coronary artery lesion or with < 50% stenosis), Group II included 47 subjects with > 50% stenosis in a single or double coronary arteries, and Group III included 30 subjects with > 50% stenosis in ≥ three coronary arteries or ≥ 50% stenosis in the left main stem. Serum levels of hs-cTn I and Str-2 were measured by the ELISA technique. Results: The median and 1st – 3rd quartile values of hs-cTn I and Str-2 levels of group III and group II were significantly higher than those of groups I (p= 0.001). The median value of hs-cTn I was significantly higher in group III than in group II (p<0.001). Receiver operating characteristic curve and area under curve tests revealed that hs-cTn I and Str-2 have a high diagnostic ability of coronary artery obstruction along with a high discriminative ability of hs-cTn I in assessment of severity of coronary artery obstruction. Conclusion: Measurements of serum Str-2 level can be used in the diagnosis of coronary artery obstruction, while serum hs-cTn I level can be used in the diagnosis and differentiation of severity of coronary artery obstruction. Combining both markers add no significant benefit
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →